Pancreas-preserving segmental duodenectomy for gastrointestinal stromal tumor of the duodenum and splenectomy for splenic angiosarcoma.

[1]  P. Morel,et al.  Segmental duodenectomy for gastrointestinal stromal tumor of the duodenum. , 2010, World journal of gastroenterology.

[2]  Xiao-Jun Yang,et al.  Duodenal gastrointestinal stromal tumor: Clinical, pathologic, immunohistochemical characteristics, and surgical prognosis , 2009, Journal of surgical oncology.

[3]  Xiaoting Wu,et al.  Synchronous incidental gastrointestinal stromal and epithelial malignant tumors. , 2009, World journal of gastroenterology.

[4]  J. Blay,et al.  Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group. , 2008, European journal of cancer.

[5]  H. van Goor,et al.  Pancreas‐preserving total duodenectomy versus standard pancreatoduodenectomy for patients with familial adenomatous polyposis and polyps in the duodenum , 2008, The British journal of surgery.

[6]  J. Thompson,et al.  Pancreas-sparing distal duodenectomy for infrapapillary neoplasms. , 2007, Annals of the Royal College of Surgeons of England.

[7]  Xin Huang,et al.  Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial , 2006, The Lancet.

[8]  L. Sobin,et al.  Occurrence of other malignancies in patients with gastrointestinal stromal tumors. , 2006, Seminars in diagnostic pathology.

[9]  A. Agaimy,et al.  Gastrointestinal Stromal Tumours in Patients with Other-Type Cancer: A Mere Coincidence or an Etiological Association? A Study of 97 GIST cases , 2005, Zeitschrift fur Gastroenterologie.

[10]  J. Cueto,et al.  Large Duodenal Villous Adenoma Requiring Head of the Pancreas and Pylorus-Preserving Total Duodenectomy , 2005, Surgical laparoscopy, endoscopy & percutaneous techniques.

[11]  C. Antonescu,et al.  A 14‐Year Retrospective Review of Angiosarcoma: Clinical Characteristics, Prognostic Factors, and Treatment Outcomes with Surgery and Chemotherapy , 2005, Cancer journal.

[12]  M. Imamura,et al.  New Pancreas-preserving Total Duodenectomy Technique , 2005, World Journal of Surgery.

[13]  J. Fletcher,et al.  KIT-Negative Gastrointestinal Stromal Tumors: Proof of Concept and Therapeutic Implications , 2004, The American journal of surgical pathology.

[14]  L. Mazzucchelli,et al.  High expression of peptide receptors as a novel target in gastrointestinal stromal tumours , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  L. Sobin,et al.  Gastrointestinal Stromal Tumors, Intramural Leiomyomas, and Leiomyosarcomas in the Duodenum: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 167 Cases , 2001, The American journal of surgical pathology.

[16]  A. D. Van den Abbeele,et al.  Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. , 2002, The New England journal of medicine.

[17]  D. Tyler,et al.  Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis , 2002, Journal of Gastrointestinal Surgery.

[18]  E. Levine,et al.  Radiation-induced gastrointestinal stromal sarcoma of the esophagus. , 2000, The Annals of thoracic surgery.

[19]  H. Suzuki,et al.  Pancreas-sparing duodenectomy for a huge leiomyosarcoma in the third portion of the duodenum. , 1999, Journal of hepato-biliary-pancreatic surgery.

[20]  J. Laissue,et al.  Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. , 1996, Cancer research.

[21]  D. Nanus,et al.  Radiation‐induced angiosarcoma , 1987, Cancer.